Drug-induced hypersensitivity reactions and pharmacogenomics: past, present and future

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

(2009) Ann K Daly et al.   NATURE GENETICS

Medications as Risk Factors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children: A Pooled Analysis

(2009) N. Levi et al.   PEDIATRICS

High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients

(2009) Gbenga R. Kazeem et al.   Pharmacogenetics and Genomics

Genetic association studies to detect adverse drug reactions: abacavir hypersensitivity as an example

(2009) Arlene R Hughes et al.   PHARMACOGENOMICS

TNF,LTA,HSPA1LandHLA-DRgene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole

(2009) Ana Alfirevic et al.   PHARMACOGENOMICS

High Sensitivity of Human Leukocyte Antigen–B*5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients

(2008) Michael Saag et al.   CLINICAL INFECTIOUS DISEASES

Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population

(2008) Chaichon Locharernkul et al.   EPILEPSIA

Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity

(2008) Diana Chessman et al.   IMMUNITY

HLA-B*5701 Screening for Hypersensitivity to Abacavir

(2008) Simon Mallal et al.   NEW ENGLAND JOURNAL OF MEDICINE

A European study of HLA-B in Stevens???Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

(2008) Christine Lonjou et al.   Pharmacogenetics and Genomics